Recombinant Human Prostatic Acid Phosphatase/ACPP, CF

R&D Systems | Catalog # 6240-AP

R&D Systems
Loading...

Key Product Details

  • R&D Systems NS0-derived Recombinant Human Prostatic Acid Phosphatase/ACPP (6240-AP)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

NS0

Accession Number

Applications

Enzyme Activity
Loading...

Product Specifications

Source

Mouse myeloma cell line, NS0-derived human Prostatic Acid Phosphatase/ACPP protein
Met1-Gln379, with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Lys33

Predicted Molecular Mass

41 kDa

SDS-PAGE

43-55 kDa, reducing conditions

Activity

Measured by its ability to cleave a substrate, p-Nitrophenyl phosphate (pNPP).
The specific activity is >100,000 pmol/min/ug, as measured under the described conditions.

Formulation, Preparation, and Storage

6240-AP
Formulation Supplied as a 0.2 μm filtered solution in Tris and NaCl.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Do not freeze.
  • 3 months from date of receipt, 2 to 8 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after opening.

Background: Prostatic Acid Phosphatase/ACPP

Prostatic Acid Phosphatase (ACPP) catalyzes the hydrolysis of a variety of phosphate monoesters, including phosphorylated proteins (1). The activity optimum of ACPP is in the pH range of 4 - 6, and the activity is inhibited by L(+)-tartrate. ACPP expression levels are highest in the prostate, with much lower expression in most other tissues. ACPP is a type I integral membrane protein of the plasma membrane and lysosomes, and a secreted form also exists (2). The concentration of ACPP is elevated in the circulation of prostate cancer patients, making the enzyme a marker for the progression of prostate cancer (3). Cellular ACPP has been shown to be a protein tyrosine phosphatase (4). Protein substrates include the epidermal growth factor receptor and HER-2 (5). Cellular ACPP is considered to function as a tumor suppressor (5).

References

  1. Apostol, I. et al. (1985) Acta. Biochim. Pol. 32:187.
  2. Schroeder, B. et al. (2007) Traffic 8:1676.
  3. Gutman, E.B. et al. (1936) Am. J. Cancer 28:485.
  4. Lin, M.F. and G.M. Clinton (1986) Biochem. J. 235:351.
  5. Veeramani, S. et al. (2005) Endocr. Relat. Cancer 12:805.

Alternate Names

ACP3, ACPP

Entrez Gene IDs

55 (Human); 563181 (Mouse); 56780 (Rat)

Gene Symbol

ACP3

UniProt

Additional Prostatic Acid Phosphatase/ACPP Products

Product Documents for Recombinant Human Prostatic Acid Phosphatase/ACPP, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Prostatic Acid Phosphatase/ACPP, CF

For research use only

Related Research Areas

Customer Reviews for Recombinant Human Prostatic Acid Phosphatase/ACPP, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Prostatic Acid Phosphatase/ACPP, CF and earn rewards!

Have you used Recombinant Human Prostatic Acid Phosphatase/ACPP, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human Prostatic Acid Phosphatase/ACPP, CF (6240-AP):

Materials
  • Assay Buffer: 50 mM NaOAc, pH 4.5
  • Recombinant Human Prostatic Acid Phosphatase/ACPP (rhACPP) (Catalog # 6240-AP)
  • Substrate: p-Nitrophenyl phosphate (Sigma-Aldrich, Catalog # N2765)
  • 96-well Clear Plate (Costar, Catalog # 92592)
  • Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent]
  • NaOH, 0.2 M in deionized water
  1. Dilute rhACPP to 0.1 μg/mL in Assay Buffer.
  2. Dilute Substrate to 2 mM in Assay Buffer.
  3. In a plate combine 50 μL of rhACPP and 50 μL of 2 mM Substrate. Include a Substrate Blank containing 50 μL Assay Buffer and 50 μL of 2 mM Substrate.
  4. Incubate reaction at room temperature for 5 minutes.
  5. Add 100 μL of 0.2 M NaOH to stop the reaction and develop the color.
  6. Read (top read) absorbance in endpoint mode at 410 nm.
  7. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Adjusted Abs* (OD) x Conversion Factor** (pmol/OD)
Incubation time (min) x amount of enzyme (µg)

     *Adjusted for Substrate Blank
     **Derived using calibration standard p-Nitrophenol (Sigma-Aldrich, Catalog # 241326).

Per Well:
  • rhACPP: 0.005 μg
  • Substrate: 0.5 mM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes